MEDROL Side Effects

6665408-2 | Ecchymosis, Epistaxis, Petechiae, Systemic Lupus Erythematosus
on Mar 24, 2010 Male patient from UKRAINE , 33 years of age, was diagnosed with systemic lupus erythematosus, nephrotic syndrome and was treated with Medrol (View Usage). Patient experienced the following unwanted or unexpected effects: ecchymosis, epistaxis, petechiae, systemic lupus erythematosus. Medrol dosage: 48mg/day. During the same period patient was treated with FUROSEMID (Unk) (View Furosemid Review and Furosemid Label ), VEROSPIRON (Unk) (View Verospiron Review and Verospiron Label ).

6654158-4 | Abasia, Osteoarthritis, Osteonecrosis, Pain In Extremity, Paraesthesia, Sleep Disorder
Patient was taking Medrol (View Usage). Patient had the following side effects: abasia, osteoarthritis (What is osteoarthritis?), osteonecrosis (What is osteonecrosis?), pain in extremity, paraesthesia, sleep disorder (What is sleep disorder?) on Mar 18, 2010 from FRANCE Additional patient health information: Male patient , weighting 160.9 lb, was diagnosed with upper limb fracture, nasopharyngitis, asthma (What is asthma?) and. Medrol dosage: . During the same period patient was treated with NASONEX (View Nasonex Review and Nasonex Label ), RHINOCORT (Unk) (View Rhinocort Review and Rhinocort Label ). Patient was hospitalized and became disabled.

6644669-X | Diabetes Mellitus
Adverse event was reported on Mar 15, 2010 by a Female patient taking Medrol (View Usage) (Dosage: 100 Mg, Unk) . Location: FRANCE , 67 years of age, After Medrol was administered, patient had the following side effects: diabetes mellitus. During the same period patient was treated with CORTANCYL (5 Mg, 1x/day) (View Cortancyl Review and Cortancyl Label ). Patient was hospitalized.

6638077-5 | Arthralgia, Pyrexia
on Mar 08, 2010 Female patient from JAPAN , 88 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Medrol (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, pyrexia. Medrol dosage: 4 Mg, 2x/day. Patient was hospitalized.


6636211-4 | Breast Mass
on Mar 04, 2010 Female patient from JAPAN , 36 years of age, was treated with Medrol (View Usage). Patient had the following side effects: breast mass. Medrol dosage: Unk. During the same period patient was treated with MEPTIN (Unk) (View Meptin Review and Meptin Label ), SYMBICORT (Unk) (View Symbicort Review and Symbicort Label ), MUCOSTA (Unk) (View Mucosta Review and Mucosta Label ).

6623976-0 | Abdominal Pain Upper, Blood Pressure Increased, Cardiac Disorder, Dysgeusia, Insomnia, Joint Swelling, Limb Injury, Regurgitation
Patient was taking Medrol (View Usage). After Medrol was administered, patient had the following side effects: abdominal pain upper, blood pressure increased, cardiac disorder, dysgeusia, insomnia, joint swelling, limb injury, regurgitation on Feb 25, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 180.0 lb, was diagnosed with joint injury, fluid retention and. Medrol dosage: 2 Mg, 1x/day. During the same period patient was treated with CARDIZEM (Unk) (View Cardizem Review and Cardizem Label ), VITAMINS (View Vitamins Review and Vitamins Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6610553-0 | Abasia, Osteoarthritis, Osteonecrosis, Pain In Extremity, Paraesthesia, Sleep Disorder
Adverse event was reported on Feb 19, 2010 by a Male patient taking Medrol (View Usage) (Dosage: ) was diagnosed with upper limb fracture, nasopharyngitis, asthma (What is asthma?) and. Location: FRANCE , weighting 160.9 lb, Patient experienced the following unwanted or unexpected effects: abasia, osteoarthritis (What is osteoarthritis?), osteonecrosis (What is osteonecrosis?), pain in extremity, paraesthesia, sleep disorder (What is sleep disorder?). During the same period patient was treated with NASONEX (View Nasonex Review and Nasonex Label ), RHINOCORT (Unk) (View Rhinocort Review and Rhinocort Label ). Patient was hospitalized and became disabled.

6606546-X | Arthralgia, Pyrexia
on Feb 15, 2010 Female patient from JAPAN , 88 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Medrol (View Usage). Patient had the following side effects: arthralgia, pyrexia. Medrol dosage: 4 Mg, 2x/day. Patient was hospitalized.

6580572-1 | Flushing, Vomiting
on Feb 05, 2010 Female patient from FRANCE , 44 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Medrol (View Usage). After Medrol was administered, patient had the following side effects: flushing, vomiting. Medrol dosage: 100 Mg, 3x/day. During the same period patient was treated with TRASTUZUMAB (720 Mg, 1x/day) (View Trastuzumab Review and Trastuzumab Label ). Patient was hospitalized.

6579538-7 | Abdominal Discomfort, Blood Cortisol Increased, Hypothyroidism, Palpitations, Vertigo, Weight Increased
Patient was taking Medrol (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal discomfort, blood cortisol increased, hypothyroidism, palpitations, vertigo, weight increased on Feb 08, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 125.0 lb, was diagnosed with adrenal disorder, hypothyroidism and. Medrol dosage: 2 Mg, 1x/day. During the same period patient was treated with THYROID TAB (Unk) (View Thyroid Tab Review and Thyroid Tab Label ). Patient was hospitalized.

6564993-9 | Erectile Dysfunction, Gait Disturbance, Myalgia
Adverse event was reported on May 15, 2007 by a Female patient taking Medrol (View Usage) (Dosage: 5 Every 1 Days) was diagnosed with pyelonephritis and. Location: FRANCE , 27 years of age, weighting 112.4 lb, Patient had the following side effects: erectile dysfunction (What is erectile dysfunction?), gait disturbance, myalgia. During the same period patient was treated with CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), DIPROSONE (View Diprosone Review and Diprosone Label ), AMOXICILLIN SODIUM (View Amoxicillin Sodium Review and Amoxicillin Sodium Label ). Patient was hospitalized and became disabled.

6552492-X | Ageusia, Anosmia, Bladder Obstruction, Cardiac Disorder, Depressed Level Of Consciousness, Intestinal Obstruction, Lung Disorder, Obstruction Gastric
on Feb 10, 2009 Female patient from BELGIUM , 50 years of age, weighting 152.1 lb, was diagnosed with bronchitis (What is bronchitis?) and was treated with Medrol (View Usage). After Medrol was administered, patient had the following side effects: ageusia, anosmia, bladder obstruction, cardiac disorder, depressed level of consciousness, intestinal obstruction, lung disorder, obstruction gastric. Medrol dosage: 32 Mg, 1x/day. During the same period patient was treated with CLARITHROMYCIN (500 Mg, 2x/day) (View Clarithromycin Review and Clarithromycin Label ).

6528495-8 | Thrombocytopenia
on Dec 28, 2009 Male patient from FRANCE , 53 years of age, was diagnosed with partial seizures and was treated with Medrol (View Usage). Patient experienced the following unwanted or unexpected effects: thrombocytopenia. Medrol dosage: 200mg/day. During the same period patient was treated with PARACETAMOL (1 G, 4x/day) (View Paracetamol Review and Paracetamol Label ), KEPPRA (500 Mg, 1x/day) (View Keppra Review and Keppra Label ), NEXIUM (20 Mg, 1x/day) (View Nexium Review and Nexium Label ). Patient was hospitalized.

6484672-6 | Asthenia, Decreased Appetite, Hyponatraemia, Malaise, Presyncope, Vomiting
Patient was taking Medrol (View Usage). Patient had the following side effects: asthenia, decreased appetite, hyponatraemia, malaise, presyncope, vomiting on Nov 26, 2009 from ITALY Additional patient health information: Female patient , 74 years of age, was diagnosed with back pain (What is back pain?), hypertension and. Medrol dosage: 16 Mg Daily. During the same period patient was treated with COVERSYL (2 Mg Daily) (View Coversyl Review and Coversyl Label ), PRIDINOL (Unk) (View Pridinol Review and Pridinol Label ), LEXOTAN (Unk) (View Lexotan Review and Lexotan Label ), ADEMETIONINE (400 Mg) (View Ademetionine Review and Ademetionine Label ). Patient was hospitalized.

6466637-3 | Basal Cell Carcinoma, Dehydration
Adverse event was reported on Nov 19, 2009 by a Female patient taking Medrol (View Usage) (Dosage: Unk) was diagnosed with dermatitis contact, osteoporosis prophylaxis, endometrial hyperplasia, depression (What is depression?), routine health maintenance and. Location: UNITED STATES , weighting 134.5 lb, After Medrol was administered, patient had the following side effects: basal cell carcinoma, dehydration. During the same period patient was treated with DIPHENHYDRAMINE (Unk) (View Diphenhydramine Review and Diphenhydramine Label ), ACTONEL (35 Mg, Weekly) (View Actonel Review and Actonel Label ), LEXAPRO (10 Mg, 1x/day) (View Lexapro Review and Lexapro Label ), MULTI VITAMINS (Unk) (View Multi-vitamins Review and Multi-vitamins Label ), LOVAZA (2 Tablets Daily) (View Lovaza Review and Lovaza Label ), CALTRATE + D (600/400 Mg) (View Caltrate + D Review and Caltrate + D Label ). Patient was hospitalized.

6460865-9 | Asthenia, Decreased Appetite, Hyponatraemia, Malaise, Presyncope, Vomiting
on Nov 19, 2009 Female patient from ITALY , 74 years of age, was diagnosed with back pain (What is back pain?), hypertension and was treated with Medrol (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, decreased appetite, hyponatraemia, malaise, presyncope, vomiting. Medrol dosage: 16 Mg Daily. During the same period patient was treated with COVERSYL (2 Mg Daily) (View Coversyl Review and Coversyl Label ), PRIDINOL (Unk) (View Pridinol Review and Pridinol Label ), LEXOTAN (Unk) (View Lexotan Review and Lexotan Label ), ADEMETIONINE (400 Mg) (View Ademetionine Review and Ademetionine Label ). Patient was hospitalized.

6457021-7 | Vomiting
on Nov 25, 2009 Female patient from UNITED STATES , weighting 117.0 lb, was diagnosed with ear pain and was treated with Medrol (View Usage). Patient had the following side effects: vomiting. Medrol dosage: Unk. During the same period patient was treated with SYNTHROID (88 Ug, 1x/day For 40 Yrs.) (View Synthroid Review and Synthroid Label ).

6447183-X | Anaphylactic Reaction, Diarrhoea, Dyspnoea, Presyncope
Patient was taking Medrol (View Usage). After Medrol was administered, patient had the following side effects: anaphylactic reaction, diarrhoea, dyspnoea, presyncope on Nov 13, 2009 from GREECE Additional patient health information: Female patient , 60 years of age, weighting 141.1 lb, . Medrol dosage: Unk. During the same period patient was treated with CELESTONE (View Celestone Review and Celestone Label ), XYLOCAINE (View Xylocaine Review and Xylocaine Label ).

6440213-0 | Bronchopulmonary Aspergillosis, Deep Vein Thrombosis, Enteritis, Hypertension, Hypotension, Interstitial Lung Disease, Left Ventricular Dysfunction, Neutropenia, Pulmonary Oedema
Adverse event was reported on Nov 12, 2009 by a Male patient taking Medrol (View Usage) (Dosage: 32 Mg, 2x/day) was diagnosed with prophylaxis of nausea and vomiting, head and neck cancer (What is head and neck cancer?) and. Location: BELGIUM , 56 years of age, Patient experienced the following unwanted or unexpected effects: bronchopulmonary aspergillosis, deep vein thrombosis (What is deep vein thrombosis?), enteritis, hypertension, hypotension, interstitial lung disease, left ventricular dysfunction, neutropenia, pulmonary oedema. During the same period patient was treated with CETUXIMAB (395 Mg, Weekly) (View Cetuximab Review and Cetuximab Label ). Patient was hospitalized.

6439954-0 | Conjunctival Irritation, Lacrimation Increased, Onycholysis
on Apr 28, 2009 Female patient from FRANCE , 43 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Medrol (View Usage). Patient had the following side effects: conjunctival irritation, lacrimation increased, onycholysis. Medrol dosage: 3 Df, Unk. During the same period patient was treated with TAXOTERE (150 Mg, Unk) (View Taxotere Review and Taxotere Label ), AVASTIN (1095 Mg, Unk) (View Avastin Review and Avastin Label ).

6438180-9 | Chest Pain
on Sep 15, 2009 Female patient from ITALY , 51 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Medrol (View Usage). After Medrol was administered, patient had the following side effects: chest pain (What is chest pain?). Medrol dosage: Unk. During the same period patient was treated with CYMBALTA (Unk) (View Cymbalta Review and Cymbalta Label ), HYDROXYCHLOROQUINE PHOSPHATE (Unk) (View Hydroxychloroquine Phosphate Review and Hydroxychloroquine Phosphate Label ), DELORAZEPAM (Unk) (View Delorazepam Review and Delorazepam Label ). Patient was hospitalized.

6437745-8 | Face Oedema, Hypokalaemia
Patient was taking Medrol (View Usage). Patient experienced the following unwanted or unexpected effects: face oedema, hypokalaemia on Nov 05, 2009 from PHILIPPINES Additional patient health information: Female patient , 15 years of age, . Medrol dosage: 16 Mg, Unk. During the same period patient was treated with MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ).

6437720-3 | Cholestasis, Cytolytic Hepatitis
Adverse event was reported on Nov 05, 2009 by a Male patient taking Medrol (View Usage) (Dosage: 16 Mg, 1x/day) was diagnosed with glioblastoma and. Location: FRANCE , 51 years of age, Patient had the following side effects: cholestasis, cytolytic hepatitis. During the same period patient was treated with NEURONTIN (Unk) (View Neurontin Review and Neurontin Label ), TEMOZOLOMIDE (Unk) (View Temozolomide Review and Temozolomide Label ), XATRAL (1 Df, 1x/day) (View Xatral Review and Xatral Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), FORLAX (View Forlax Review and Forlax Label ), DIFFU K (View Diffu K Review and Diffu K Label ). Patient was hospitalized.

6428653-7 | Bronchopulmonary Aspergillosis, Multi-organ Failure
on Oct 26, 2009 Male patient from BELGIUM , 75 years of age, was diagnosed with anaemia haemolytic autoimmune, bronchopulmonary aspergillosis and was treated with Medrol (View Usage). After Medrol was administered, patient had the following side effects: bronchopulmonary aspergillosis, multi-organ failure. Medrol dosage: 64 Mg, 1x/day. During the same period patient was treated with VORICONAZOLE (View Voriconazole Review and Voriconazole Label ), ACETYLSALICYLIC ACID (160 Mg, 1x/day) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ). Patient was hospitalized.

6416216-9 | Asthenia, Decreased Appetite, Hyponatraemic Syndrome, Malaise, Presyncope, Vomiting
on Oct 20, 2009 Female patient from ITALY , 74 years of age, was diagnosed with back pain (What is back pain?), hypertension and was treated with Medrol (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, decreased appetite, hyponatraemic syndrome, malaise, presyncope, vomiting. Medrol dosage: 16 Mg Daily. During the same period patient was treated with COVERSYL (2 Mg Daily) (View Coversyl Review and Coversyl Label ), PRIDINOL (Unk) (View Pridinol Review and Pridinol Label ), LEXOTAN (Unk) (View Lexotan Review and Lexotan Label ). Patient was hospitalized.

6408229-8 | Vomiting
Patient was taking Medrol (View Usage). Patient had the following side effects: vomiting on Oct 08, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 117.0 lb, was diagnosed with ear pain and. Medrol dosage: Unk. During the same period patient was treated with SYNTHROID (88 Ug, 1x/day For 40 Yrs.) (View Synthroid Review and Synthroid Label ).

6405062-8 | Asthenia, Decreased Appetite, Hyponatraemic Syndrome, Malaise, Presyncope, Vomiting
Adverse event was reported on Oct 07, 2009 by a Female patient taking Medrol (View Usage) (Dosage: 16 Mg Daily) was diagnosed with back pain (What is back pain?), hypertension and. Location: ITALY , 74 years of age, After Medrol was administered, patient had the following side effects: asthenia, decreased appetite, hyponatraemic syndrome, malaise, presyncope, vomiting. During the same period patient was treated with COVERSYL (2 Mg Daily) (View Coversyl Review and Coversyl Label ), PRIDINOL (Unk) (View Pridinol Review and Pridinol Label ), LEXOTAN (Unk) (View Lexotan Review and Lexotan Label ). Patient was hospitalized.

6400674-X | Bronchopulmonary Aspergillosis, Deep Vein Thrombosis, Enteritis, Hypertension, Hypotension, Interstitial Lung Disease, Left Ventricular Dysfunction, Neutropenia, Pulmonary Oedema
on Oct 02, 2009 Female patient from BELGIUM , 56 years of age, was diagnosed with prophylaxis of nausea and vomiting, head and neck cancer (What is head and neck cancer?) and was treated with Medrol (View Usage). Patient experienced the following unwanted or unexpected effects: bronchopulmonary aspergillosis, deep vein thrombosis (What is deep vein thrombosis?), enteritis, hypertension, hypotension, interstitial lung disease, left ventricular dysfunction, neutropenia, pulmonary oedema. Medrol dosage: 32 Mg, 2x/day. During the same period patient was treated with CETUXIMAB (395 Mg, Weekly) (View Cetuximab Review and Cetuximab Label ). Patient was hospitalized.

6398905-8 | Asthenia, Decreased Appetite, Hyponatraemic Syndrome, Malaise, Presyncope, Vomiting
on Oct 01, 2009 Female patient from ITALY , 74 years of age, was diagnosed with back pain (What is back pain?), hypertension and was treated with Medrol (View Usage). Patient had the following side effects: asthenia, decreased appetite, hyponatraemic syndrome, malaise, presyncope, vomiting. Medrol dosage: 16 Mg Daily. During the same period patient was treated with COVERSYL (2 Mg Daily) (View Coversyl Review and Coversyl Label ), PRIDINOL (Unk) (View Pridinol Review and Pridinol Label ), LEXOTAN (Unk) (View Lexotan Review and Lexotan Label ). Patient was hospitalized.

6394970-2 | Cushingoid, Liver Function Test Abnormal, Oedema, Purpura
Patient was taking Medrol (View Usage). After Medrol was administered, patient had the following side effects: cushingoid, liver function test abnormal, oedema, purpura on Sep 29, 2009 from JAPAN Additional patient health information: Female patient , 72 years of age, was diagnosed with aplastic anaemia and. Medrol dosage: 8mg/day. During the same period patient was treated with NEORAL (Unk) (View Neoral Review and Neoral Label ), TAKEPRON (Unk) (View Takepron Review and Takepron Label ), LASIX (Unk) (View Lasix Review and Lasix Label ), PRIMOBOLAN (Unk) (View Primobolan Review and Primobolan Label ), PERSANTINE (Unk) (View Persantine Review and Persantine Label ), MARZULENE S (Unk) (View Marzulene S Review and Marzulene S Label ).

6394141-X | Bronchopulmonary Aspergillosis
Adverse event was reported on Sep 28, 2009 by a Female patient taking Medrol (View Usage) (Dosage: ) was diagnosed with head and neck cancer (What is head and neck cancer?) and. Location: BELGIUM , 56 years of age, Patient experienced the following unwanted or unexpected effects: bronchopulmonary aspergillosis. During the same period patient was treated with CETUXIMAB (View Cetuximab Review and Cetuximab Label ), DOCETAXEL (View Docetaxel Review and Docetaxel Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), NULYTELY (View Nulytely Review and Nulytely Label ).

6382932-0 | International Normalised Ratio Increased
on Sep 17, 2009 Female patient from FRANCE , 80 years of age, was diagnosed with temporal arteritis, atrial fibrillation (What is atrial fibrillation?) and was treated with Medrol (View Usage). Patient had the following side effects: international normalised ratio increased. Medrol dosage: 16 Mg, Alternate Day. During the same period patient was treated with PREVISCAN (10 Mg, 1x/day) (View Previscan Review and Previscan Label ), EURELIX (View Eurelix Review and Eurelix Label ), TENORMIN (View Tenormin Review and Tenormin Label ), LERCANIDIPINE (View Lercanidipine Review and Lercanidipine Label ), TRIVASTAL (View Trivastal Review and Trivastal Label ), CETORNAN (View Cetornan Review and Cetornan Label ). Patient was hospitalized.

6382930-7 | Psychotic Disorder
on Sep 17, 2009 Female patient from PHILIPPINES , 37 years of age, was diagnosed with optic neuritis and was treated with Medrol (View Usage). After Medrol was administered, patient had the following side effects: psychotic disorder (What is psychotic disorder?). Medrol dosage: 16 Mg, 3x/day. During the same period patient was treated with SOLU MEDROL (500 Mg, Unk) (View Solu-medrol Review and Solu-medrol Label ). Patient was hospitalized.

6377272-X | Cholestasis, Cytolytic Hepatitis
Patient was taking Medrol (View Usage). Patient experienced the following unwanted or unexpected effects: cholestasis, cytolytic hepatitis on Sep 17, 2009 from FRANCE Additional patient health information: Female patient , 51 years of age, was diagnosed with glioblastoma and. Medrol dosage: 16 Mg, 1x/day. During the same period patient was treated with NEURONTIN (Unk) (View Neurontin Review and Neurontin Label ), TEMOZOLOMIDE (Unk) (View Temozolomide Review and Temozolomide Label ), XATRAL (1 Df, 1x/day) (View Xatral Review and Xatral Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), FORLAX (View Forlax Review and Forlax Label ), DIFFU K (View Diffu K Review and Diffu K Label ). Patient was hospitalized.

6367708-2 | Psychotic Disorder
Adverse event was reported on Sep 14, 2009 by a Female patient taking Medrol (View Usage) (Dosage: 16 Mg, 3x/day) was diagnosed with optic neuritis and. Location: PHILIPPINES , 37 years of age, Patient had the following side effects: psychotic disorder (What is psychotic disorder?). During the same period patient was treated with SOLU MEDROL (500 Mg, Unk) (View Solu-medrol Review and Solu-medrol Label ). Patient was hospitalized.

6345545-2 | Eye Operation, Haemorrhage Subcutaneous
on Aug 26, 2009 Female patient from JAPAN , 67 years of age, was treated with Medrol (View Usage). After Medrol was administered, patient had the following side effects: eye operation, haemorrhage subcutaneous. Medrol dosage: 4 Mg, 1x/day. During the same period patient was treated with RHEUMATREX (6 Mg, Weekly) (View Rheumatrex Review and Rheumatrex Label ). Patient was hospitalized.

6345538-5 | Cushingoid, Liver Function Test Abnormal, Oedema, Purpura
on Aug 27, 2009 Female patient from JAPAN , 72 years of age, was diagnosed with aplastic anaemia and was treated with Medrol (View Usage). Patient experienced the following unwanted or unexpected effects: cushingoid, liver function test abnormal, oedema, purpura. Medrol dosage: 8mg/day. During the same period patient was treated with NEORAL (Unk) (View Neoral Review and Neoral Label ), TAKEPRON (Unk) (View Takepron Review and Takepron Label ), LASIX (Unk) (View Lasix Review and Lasix Label ), PRIMOBOLAN (Unk) (View Primobolan Review and Primobolan Label ), PERSANTINE (Unk) (View Persantine Review and Persantine Label ), MARZULENE S (Unk) (View Marzulene S Review and Marzulene S Label ).

6310408-5 | Gait Disturbance, Muscular Weakness, Osteopenia
Patient was taking Medrol (View Usage). Patient had the following side effects: gait disturbance, muscular weakness, osteopenia on Aug 14, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 140.0 lb, was diagnosed with ear disorder, viral infection (What is viral infection?), bacterial infection (What is bacterial infection?) and. Medrol dosage: . During the same period patient was treated with PREDNISONE (Unk) (View Prednisone Review and Prednisone Label ), AVELOX (View Avelox Review and Avelox Label ), AUGMENTIN (View Augmentin Review and Augmentin Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ).

6297296-0 | Lymphadenopathy, Oral Candidiasis
Adverse event was reported on Jul 29, 2009 by a Female patient taking Medrol (View Usage) (Dosage: 16 Mg, 3x/day) was diagnosed with bronchitis (What is bronchitis?) and. Location: FRANCE , 39 years of age, After Medrol was administered, patient had the following side effects: lymphadenopathy, oral candidiasis. During the same period patient was treated with CLARITHROMYCIN (500 Mg, Unk) (View Clarithromycin Review and Clarithromycin Label ), PNEUMOREL (Unk) (View Pneumorel Review and Pneumorel Label ), FLUTICASONE PROPIONATE (Unk) (View Fluticasone Propionate Review and Fluticasone Propionate Label ), LERCAN (View Lercan Review and Lercan Label ), PRITOR (View Pritor Review and Pritor Label ), DEROXAT (View Deroxat Review and Deroxat Label ), VASTAREL (View Vastarel Review and Vastarel Label ).

6286762-X | Conjunctival Irritation, Lacrimation Increased, Onycholysis
on May 11, 2009 Female patient from FRANCE , 43 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Medrol (View Usage). Patient experienced the following unwanted or unexpected effects: conjunctival irritation, lacrimation increased, onycholysis. Medrol dosage: 3 Df, Unk. During the same period patient was treated with TAXOTERE (150 Mg, Unk) (View Taxotere Review and Taxotere Label ), AVASTIN (1095 Mg, Unk) (View Avastin Review and Avastin Label ).

6278120-9 | Deep Vein Thrombosis, Glomerulonephritis Membranous, Hyperlipidaemia, Hypertension
on Jul 08, 2009 Female patient from GREECE , 40 years of age, was treated with Medrol (View Usage). Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), glomerulonephritis membranous, hyperlipidaemia, hypertension. Medrol dosage: 32 Mg, 1x/day. During the same period patient was treated with AZATHIOPRINE (100 Mg, 1x/day) (View Azathioprine Review and Azathioprine Label ), TINZAPARIN SODIUM (14.000 Iu, 1x/day) (View Tinzaparin Sodium Review and Tinzaparin Sodium Label ), FUROSEMIDE (40 Mg, 1x/day) (View Furosemide Review and Furosemide Label ), ATENOLOL (25 Mg, 1x/day) (View Atenolol Review and Atenolol Label ), PRIMIDONE (375 Mg, 1x/day) (View Primidone Review and Primidone Label ), CALCIUM CARBONATE (500 Mg, 1x/day) (View Calcium Carbonate Review and Calcium Carbonate Label ), CALCIDOL (Unk) (View Calcidol Review and Calcidol Label ), OLMESARTAN MEDOXOMIL (20 Mg, Unk) (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ). Patient was hospitalized.

6268440-6 | Gait Disturbance, Muscular Weakness, Osteopenia
Patient was taking Medrol (View Usage). After Medrol was administered, patient had the following side effects: gait disturbance, muscular weakness, osteopenia on Jul 02, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 140.0 lb, was diagnosed with ear disorder, viral infection (What is viral infection?), bacterial infection (What is bacterial infection?) and. Medrol dosage: . During the same period patient was treated with PREDNISONE (Unk) (View Prednisone Review and Prednisone Label ), AVELOX (View Avelox Review and Avelox Label ), AUGMENTIN (View Augmentin Review and Augmentin Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ).

6265679-0 | Deep Vein Thrombosis, Glomerulonephritis Membranous, Hyperlipidaemia, Hypertension
Adverse event was reported on Jul 08, 2009 by a Female patient taking Medrol (View Usage) (Dosage: 32 Mg, 1x/day) . Location: GREECE , 40 years of age, Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?), glomerulonephritis membranous, hyperlipidaemia, hypertension. During the same period patient was treated with OLMESARTAN MEDOXOMIL (20 Mg, Unk) (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ), AZATHIOPRINE (100 Mg, 1x/day) (View Azathioprine Review and Azathioprine Label ), TINZAPARIN SODIUM (14.000 Iu, 1x/day) (View Tinzaparin Sodium Review and Tinzaparin Sodium Label ), FUROSEMIDE (40 Mg, 1x/day) (View Furosemide Review and Furosemide Label ), ATENOLOL (25 Mg, 1x/day) (View Atenolol Review and Atenolol Label ), PRIMIDONE (375 Mg, 1x/day) (View Primidone Review and Primidone Label ), CALCIUM CARBONATE (500 Mg, 1x/day) (View Calcium Carbonate Review and Calcium Carbonate Label ), CALCIDOL (Unk) (View Calcidol Review and Calcidol Label ). Patient was hospitalized.

6255058-4 | Deep Vein Thrombosis, Glomerulonephritis Membranous, Hyperlipidaemia, Hypertension
on Jun 29, 2009 Female patient from GREECE , 40 years of age, was treated with Medrol (View Usage). Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), glomerulonephritis membranous, hyperlipidaemia, hypertension. Medrol dosage: 32 Mg, 1x/day. During the same period patient was treated with OLMESARTAN MEDOXOMIL (20 Mg, Unk) (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ), AZATHIOPRINE (100 Mg, 1x/day) (View Azathioprine Review and Azathioprine Label ), TINZAPARIN SODIUM (14.000 Iu, 1x/day) (View Tinzaparin Sodium Review and Tinzaparin Sodium Label ), FUROSEMIDE (40 Mg, 1x/day) (View Furosemide Review and Furosemide Label ), ATENOLOL (25 Mg, 1x/day) (View Atenolol Review and Atenolol Label ), PRIMIDONE (375 Mg, 1x/day) (View Primidone Review and Primidone Label ), CALCIUM CARBONATE (500 Mg, 1x/day) (View Calcium Carbonate Review and Calcium Carbonate Label ), CALCIDOL (Unk) (View Calcidol Review and Calcidol Label ). Patient was hospitalized.

6242436-2 | Hydrocephalus, Malaise
on Jun 22, 2009 Male patient from UNITED STATES , 45 years of age, weighting 200.0 lb, was treated with Medrol (View Usage). After Medrol was administered, patient had the following side effects: hydrocephalus (What is hydrocephalus?), malaise. Medrol dosage: Medrol Pac. Patient was hospitalized.

6231023-8 | Tendon Injury, Tendon Pain
Patient was taking Medrol (View Usage). Patient experienced the following unwanted or unexpected effects: tendon injury, tendon pain on Jun 12, 2009 from ITALY Additional patient health information: Female patient , 77 years of age, was diagnosed with asthma (What is asthma?) and. Medrol dosage: 16 Mg, 1x/day. During the same period patient was treated with TAVANIC (500 Mg, 1x/day) (View Tavanic Review and Tavanic Label ), FOSTER 100/6 (100 Mcg/6 Mcg) (View Foster 100/6 Review and Foster 100/6 Label ).

6219289-1 | Tendon Injury, Tendon Pain
Adverse event was reported on Jun 03, 2009 by a Female patient taking Medrol (View Usage) (Dosage: 16 Mg, 1x/day) was diagnosed with asthma (What is asthma?) and. Location: ITALY , 77 years of age, Patient had the following side effects: tendon injury, tendon pain. During the same period patient was treated with TAVANIC (500 Mg, 1x/day) (View Tavanic Review and Tavanic Label ), FOSTER 100/6 (100 Mcg/6 Mcg) (View Foster 100/6 Review and Foster 100/6 Label ).

6219025-9 | Rash Pustular
on May 27, 2009 Female patient from JAPAN , 58 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Medrol (View Usage). After Medrol was administered, patient had the following side effects: rash pustular. Medrol dosage: 1 Mg, 1x/day. During the same period patient was treated with ETANERCEPT (25 Mg, Weekly) (View Etanercept Review and Etanercept Label ), CYCLOSPORINE (50 Mg, 1x/day) (View Cyclosporine Review and Cyclosporine Label ). Patient was hospitalized.

6211725-X | Pneumonia, Pulmonary Fibrosis
on May 20, 2009 Female patient from CHINA , 28 years of age, was diagnosed with nephrotic syndrome and was treated with Medrol (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonia (What is pneumonia?), pulmonary fibrosis (What is pulmonary fibrosis?). Medrol dosage: 40 Mg, 1x/day. During the same period patient was treated with LEFLUNOMIDE (20 Mg, 1x/day) (View Leflunomide Review and Leflunomide Label ).

6184739-6 | Conjunctival Irritation, Lacrimation Increased, Onycholysis
Patient was taking Medrol (View Usage). Patient had the following side effects: conjunctival irritation, lacrimation increased, onycholysis on Apr 28, 2009 from FRANCE Additional patient health information: Female patient , 43 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Medrol dosage: 3 Df, Unk. During the same period patient was treated with TAXOTERE (150 Mg, Unk) (View Taxotere Review and Taxotere Label ), AVASTIN (1095 Mg, Unk) (View Avastin Review and Avastin Label ).